CytomX Therapeutics, Inc.

WHITTIER TRUST CO CTMX

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/27/2026

11,458

Value ($000)

Weight

0.0%

2019 Q4 - 2026 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/27/2026	44	0.0%	11,458	6/30/2026
2024 Q2	7/29/2024	3	0.0%	2,200	6/30/2024
2024 Q1	5/2/2024	14	0.0%	6,604	3/31/2024
2023 Q4	1/11/2024	10	0.0%	6,604	12/31/2023
2023 Q3	10/27/2023	8	0.0%	6,604	9/30/2023
2023 Q2	7/24/2023	14	0.0%	8,363	6/30/2023
2023 Q1	4/21/2023	13	0.0%	8,363	3/31/2023
2022 Q4	1/25/2023	13	0.0%	8,363	12/31/2022
2022 Q3	10/21/2022	12	0.0%	8,363	9/30/2022
2022 Q2	7/28/2022	15	0.0%	8,363	6/30/2022
2022 Q1	4/29/2022	29	0.0%	11,008	3/31/2022
2021 Q4	1/19/2022	48	0.0%	11,008	12/31/2021
2021 Q3	11/1/2021	56	0.0%	11,008	9/30/2021
2021 Q2	7/29/2021	70	0.0%	11,008	6/30/2021
2021 Q1	4/26/2021	85	0.0%	11,008	3/31/2021
2020 Q4	1/29/2021	72	0.0%	11,008	12/31/2020
2020 Q3	10/30/2020	73	0.0%	11,008	9/30/2020
2020 Q2	7/10/2020	92	0.0%	11,008	6/30/2020
2020 Q1	4/27/2020	84	0.0%	11,008	3/31/2020
2019 Q4	1/31/2020	91	0.0%	11,008	12/31/2019